Loading…
Distinct Biomarker Profiles in Ex-vivo T cell depletion Graft Manipulation Strategies: CD34+ Selection vs CD3+/19+ Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation
Various approaches have been developed for ex vivo T cell depletion in allogeneic stem cell transplantation to prevent graft versus host disease (GVHD). However, direct comparisons between T-cell depletion strategies have not been well studied. We evaluated cellular and plasma biomarkers in two diff...
Saved in:
Published in: | Biology of blood and marrow transplantation 2017-11, Vol.24 (3), p.460-466 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Various approaches have been developed for
ex vivo
T cell depletion in allogeneic stem cell transplantation to prevent graft versus host disease (GVHD). However, direct comparisons between T-cell depletion strategies have not been well studied. We evaluated cellular and plasma biomarkers in two different graft manipulation strategies: CD3
+
CD19
+
cell depletion (CD3/19D) versus CD34
+
selection (CD34S) and their association with clinical outcomes. Identical conditions including the myeloablative preparative regimen, HLA-identical sibling donor, GVHD prophylaxis, and graft source were used for each cohort. Major clinical outcomes were similar between the two groups in terms of overall survival, non-relapse mortality, and cumulative incidence of relapse, however, the cumulative incidence of acute GVHD trended to be higher in CD3/19D compared to CD34S. A distinct biomarker profile was noted in the CD3/19D cohort: higher levels of ST2, impaired Helios
−
FoxP3
+
T
regs
reconstitution, and rapid reconstitution of naïve, Th2, and Th17 CD4 cells in the early post-transplant period. In vitro graft replication studies confirmed that CD3/19D disproportionately depleted T
regs
and other CD4 subset repertoires in the graft. This study confirmed the utility of biomarker monitoring which can be directly correlated to biological consequences and possible future therapeutic indications. |
---|---|
ISSN: | 1083-8791 1523-6536 |
DOI: | 10.1016/j.bbmt.2017.11.028 |